Novo Nordisk A/S buy Luise1
Summary
This prediction ended on 26.11.15 with a price of €49.39. The BUY prediction by Luise1 for Novo Nordisk A/S saw massive gains of 41.60%. Luise1 has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S | - | - | - | - |
| iShares Core DAX® | -2.023% | -3.140% | 10.499% | 13.078% |
| iShares Nasdaq 100 | 4.625% | 8.753% | 34.939% | 57.906% |
| iShares Nikkei 225® | -2.088% | -0.980% | 3.292% | 2.524% |
| iShares S&P 500 | 2.398% | 4.677% | 27.998% | 49.604% |
Comments by Luise1 for this prediction
In the thread Novo Nordisk A/S diskutieren
Dauerbrenner
Diabetes? Kaufen selbst in Asien wird die Bevölkerung fetter...
update vom 19.01.15: Aktienrückkäufe werden die Papiere über die 40€ Marke steigen lassen
update vom 23.02.15: Ausbruch vollzogen, neues Kursziel 50€
update vom 23.04.15: Kurszielerhöhung auf 56€
update vom 10.06.15: Nachkaufsignal
Stopped prediction by Luise1 for Novo Nordisk A/S
Novo Nordisk A/S
14.09.19
04.11.21
05.11.21
